Five CMS Payment and Coverage Actions from November 2020

Archive context (November 2020): These five CMS actions were issued or proposed in October and November 2020. Dollar amounts, proposed rates, vaccine payment figures and deadlines are historical, not current policy. Original reporting: Morgan Haefner, Becker’s Hospital Review, November 5, 2020. For Medicare home health policy, see current CMS guidance.
CMS released or proposed five rules since Oct. 28 concerning new payment reforms, price transparency regulations and coverage of a COVID-19 vaccine.
Here’s a breakdown of the five rules and proposals, beginning with the most recent:
1. CMS released a final rule Nov. 2 that updates payment rates for dialysis services. It takes effect Jan. 1. The agency is expanding add-on payments for new and innovative equipment and supplies to certain home dialysis machines. In 2021, CMS expects to pay $10.3 billion to about 7,400 dialysis facilities in the prospective payment system.
2. On Nov. 2, CMS issued part two of its proposed 2022 Medicare Advantage Advance Notice. The rule updates payment methodologies to Medicare Advantage and Part D plans. Among its provisions, the rule increases payment rates to Medicare Advantage plans by 2.82 percent compared to last year. CMS also wants to change how it uses risk scores to calculate payment to Medicare Advantage plans in 2022.
3. CMS unveiled a final rule Oct. 29 that requires health plans to disclose the rates they negotiate with hospitals and other healthcare providers. The final rule requires health insurers to offer an online tool that provides members with personalized out-of-pocket cost information and the negotiated rates for all covered services and items, including prescription drugs. Health plans must also provide this information in paper form if it is requested.
4. CMS finalized 2021 payment updates for home health agencies Oct. 29. CMS will increase payments to home health agencies by about 1.9 percent, or $390 million, for 2021. Under the 2021 rule, home health agencies could use telecommunications, including remote patient monitoring, as part of the plan of care, but such technology could not replace an ordered in-person visit or count as a visit for Medicare eligibility or payment.
5. CMS said Oct. 28 that under an interim final rule, Medicare, Medicaid and private insurers will all be required to cover a COVID-19 vaccine without any out-of-pocket costs for beneficiaries and members. CMS said the Medicare rate for a single-dose vaccine will be $28.39, and a vaccine with two or more doses will be reimbursed at $16.94 for initial doses and $28.39 for the final.
Move from information to action
See how the N9+ can fit your organization.
Explore the remote physical exam platform or request a focused demonstration.